https://www.selleckchem.com/pr....oducts/finerenone.ht
The prognostic performance of all models was validated using a test set with integrated Brier scores. This study included 81 patients (training cohort=57; test cohort=24), and the mean PFS was 57.5 ± 43.6 months. In the training cohort, the prognostic performances of survival models improved significantly with the addition of radiomics to the clinical (iAUC, 0.72-0.80; p=0.04), stage (iAUC, 0.70-0.79; p=0.001), and combined models (iAUC, 0.76-0.81; p0.001). In the test cohort, the radiomics and combined survival models were robus